• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Watts Water Technologies Names Ryan Lada as Chief Financial Officer

    7/14/25 9:00:00 AM ET
    $GE
    $IEX
    $MDT
    $WTS
    Consumer Electronics/Appliances
    Technology
    Fluid Controls
    Industrials
    Get the next $GE alert in real time by email

    Watts Water Technologies, Inc. (NYSE:WTS) today announced that Ryan Lada has been appointed Chief Financial Officer effective July 28, 2025. Mr. Lada succeeds current Chief Financial Officer Shashank Patel, who previously announced his intent to retire in October 2024.

    Mr. Lada joins Watts from The AZEK Company, where he most recently served as Senior Vice President, Chief Financial Officer and Treasurer and was responsible for overseeing AZEK's enterprise-wide financial operations, overall financial and capital allocation strategy, and investor relations efforts. Mr. Lada departed AZEK on July 11, 2025 following its acquisition by James Hardie Industries.

    Chief Executive Officer, President and Chair of the Board, Robert J. Pagano, Jr. said, "We are excited to welcome Ryan to Watts as our next CFO. Ryan brings a track record for driving performance at leading global manufacturing companies and delivering exceptional results. He is a proven leader offering strong financial acumen, strategic vision, global M&A experience, and operating rigor. We are confident that Ryan will be a key contributor in helping us capitalize on profitable growth opportunities, navigate global market dynamics, and deliver sustained value to our stockholders."

    Mr. Lada previously held the role of Vice President of Corporate Finance and Chief Financial Officer of AZEK's Residential and Commercial segments. Before joining AZEK, he held several senior finance roles of increasing responsibility with Cantel Medical Corporation, including Vice President of Investor Relations and Treasury, Chief Financial Officer of the Global Medical Division and Chief Financial Officer for the Europe, Middle East and Africa region. Earlier in his career, Mr. Lada held financial leadership positions at General Electric Company (NYSE:GE), IDEX Corporation (NYSE:IEX) and Medtronic, Inc. (NYSE:MDT), building a strong foundation in public company operational finance, corporate development, and global financial planning. Mr. Lada earned a Six Sigma Black Belt certification in finance while at GE and holds a Bachelor of Science degree in Finance from The Black School of Business at Pennsylvania State University.

    Mr. Lada commented, "Watts impressed me with its iconic portfolio of global brands, strong 150+ year heritage and culture, and track record of innovation and growth in support of water efficiency, safety, and delivery. I am excited by the opportunity to partner with Bob and the team to help shape Watts' next chapter of profitable growth and deliver stakeholder value through financial vision and execution, strategic capital deployment, and commercial and operational excellence."

    Mr. Pagano concluded, "On behalf of our entire organization, I would like to also extend my gratitude to Shashank for his partnership, dedication, and impactful contributions over his seven years with Watts and for his willingness to provide extended assistance in transitioning his responsibilities to Ryan to ensure a seamless succession. We wish Shashank the very best on his well-earned retirement."

    About Watts Water Technologies, Inc.

    Watts Water Technologies, Inc., through its family of companies, is a global manufacturer headquartered in the USA that provides one of the broadest plumbing, heating, and water quality product lines in the world. Watts Water companies and brands offer innovative plumbing, heating, and water quality solutions to control the efficiency, safety, and quality of water within commercial, residential, and industrial applications. For more information visit www.watts.com.

    This press release includes "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995, including statements relating to capitalizing on growth opportunities, navigating turbulent market dynamics, realizing cost savings and delivering sustained value to our stockholders. These forward-looking statements reflect our current views about future events. You should not rely on forward-looking statements because our actual results may differ materially from those predicted as a result of a number of potential risks and uncertainties. These potential risks and uncertainties include, but are not limited to: the imposition of or changes to tariff rates; the effectiveness, timing and expected savings associated with our cost-cutting actions, restructuring and initiatives; integration of acquired businesses in a timely and cost-effective manner, retention of supplier and customer relationships and key employees, and the ability to achieve synergies and cost savings in the amounts and within the time frames currently anticipated; current economic and financial conditions, which can affect the housing and construction markets where our products are sold, manufactured and marketed; shortages in and pricing of raw materials and supplies; our ability to compete effectively; changes in variable interest rates on our borrowings; inflation; failure to expand our markets through acquisitions; failure to successfully develop and introduce new product offerings or enhancements to existing products; failure to manufacture products that meet required performance and safety standards; foreign exchange rate fluctuations; cyclicality of industries where we market our products, such as plumbing and heating wholesalers and home improvement retailers; environmental compliance costs; product liability risks and costs; changes in the status of current litigation; the war in Ukraine and other global crises; supply chain and logistical disruptions or labor shortages and workforce disruptions that could negatively affect our supply chain, manufacturing, distribution, or other business processes; and other risks and uncertainties discussed under the heading "Item 1A. Risk Factors" and in Note 16 of the Notes to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission ("SEC"), as well as risk factors disclosed in our subsequent filings with the SEC. We undertake no duty to update the information contained in this press release, except as required by law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250714797715/en/

    Watts Water Technologies, Inc.

    Diane McClintock

    Senior Vice President FP&A and Investor Relations

    Telephone: 978-689-6153

    Email: [email protected]

    Get the next $GE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GE
    $IEX
    $MDT
    $WTS

    CompanyDatePrice TargetRatingAnalyst
    Watts Water Technologies Inc.
    $WTS
    9/19/2025$287.00Equal Weight
    Barclays
    Medtronic plc.
    $MDT
    6/30/2025Underperform → Peer Perform
    Wolfe Research
    Medtronic plc.
    $MDT
    6/16/2025$110.00Outperform
    Leerink Partners
    GE Aerospace
    $GE
    5/19/2025Buy → Neutral
    Northcoast
    Watts Water Technologies Inc.
    $WTS
    5/16/2025Buy → Neutral
    Northcoast
    Watts Water Technologies Inc.
    $WTS
    4/16/2025$229.00Hold → Buy
    Stifel
    GE Aerospace
    $GE
    4/9/2025$205.00Neutral → Buy
    Northcoast
    Medtronic plc.
    $MDT
    3/4/2025$92.00 → $107.00Neutral → Buy
    Citigroup
    More analyst ratings

    $GE
    $IEX
    $MDT
    $WTS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Jellison William R bought $462,750 worth of Ordinary Shares (5,000 units at $92.55) (SEC Form 4)

    4 - Medtronic plc (0001613103) (Issuer)

    8/25/25 5:18:06 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Helmkamp Katrina L bought $399,026 worth of shares (2,500 units at $159.61), increasing direct ownership by 23% to 13,200 units (SEC Form 4)

    4 - IDEX CORP /DE/ (0000832101) (Issuer)

    8/11/25 4:22:26 PM ET
    $IEX
    Fluid Controls
    Industrials

    $GE
    $IEX
    $MDT
    $WTS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Watts Water Tech. with a new price target

    Barclays initiated coverage of Watts Water Tech. with a rating of Equal Weight and set a new price target of $287.00

    9/19/25 8:40:08 AM ET
    $WTS
    Metal Fabrications
    Industrials

    Medtronic upgraded by Wolfe Research

    Wolfe Research upgraded Medtronic from Underperform to Peer Perform

    6/30/25 7:56:30 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Leerink Partners initiated coverage on Medtronic with a new price target

    Leerink Partners initiated coverage of Medtronic with a rating of Outperform and set a new price target of $110.00

    6/16/25 7:51:25 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $GE
    $IEX
    $MDT
    $WTS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes

    GALWAY, Ireland, Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public offering (the "Offering") of €750,000,000 principal amount of 2.950% senior notes due 2030 and €750,000,000 principal amount of 4.200% senior notes due 2045 (collectively, the "Notes"). All of Medtronic, Inc.'s obligations under the Notes are fully and unconditionally guaranteed by the Company and Medtronic Global Holdings S.C.A. ("Medtronic Luxco"), a wholly-owned subsidiary of the Company and the indirect parent of Medtronic, Inc., on a senior unsecured basis. The net proceeds from the Offering a

    9/29/25 8:09:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Kratos and GE Aerospace's Small Engine Testing Gains Altitude

    GEK800 Small Engine Designed to Power the Next Generation of Affordable Unmanned Aerial Systems and CCA-type Aircraft AFRL, GE Aerospace, Kratos Defense, and Purdue Zucrow Labs Collaborating on Extremely Tight Testing Timeline SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), a Technology Company in the Defense, National Security and Global Markets, and GE Aerospace (NYSE:GE) announced that they have started altitude testing on its GEK800 small engine designed to power the next generation of affordable unmanned aerial systems and CCA-type aircraft. The testing began today at an altitude test facility at Purdue University's Maurice

    9/23/25 9:30:00 AM ET
    $GE
    $KTOS
    Consumer Electronics/Appliances
    Technology
    Military/Government/Technical
    Industrials

    Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence

    The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, announced today that it has received U.S. Food and Drug Administration (FDA) approval for the Altaviva™ device. The minimally invasive implantable tibial neuromodulation (ITNM) therapy is inserted near the ankle and designed to treat urge urinary incontinence.   Bladder control problems affect an estimated 43

    9/19/25 8:00:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $GE
    $IEX
    $MDT
    $WTS
    SEC Filings

    View All

    SEC Form 25-NSE filed by Medtronic plc.

    25-NSE - Medtronic plc (0001613103) (Subject)

    9/29/25 10:44:27 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form CERT filed by Medtronic plc.

    CERT - Medtronic plc (0001613103) (Filer)

    9/29/25 9:53:17 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 8-K filed by Medtronic plc.

    8-K - Medtronic plc (0001613103) (Filer)

    9/29/25 8:45:28 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $GE
    $IEX
    $MDT
    $WTS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & President Cardiovascular Kiil Harry Skip sold $788,048 worth of Ordinary Shares (8,605 units at $91.58), decreasing direct ownership by 19% to 35,615 units (SEC Form 4)

    4 - Medtronic plc (0001613103) (Issuer)

    9/5/25 4:18:13 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Senior Vice President Ghai Rahul converted options into 52,488 shares and covered exercise/tax liability with 24,324 shares, increasing direct ownership by 54% to 80,570 units (SEC Form 4)

    4 - GENERAL ELECTRIC CO (0000040545) (Issuer)

    9/3/25 4:10:26 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    Director Jellison William R bought $462,750 worth of Ordinary Shares (5,000 units at $92.55) (SEC Form 4)

    4 - Medtronic plc (0001613103) (Issuer)

    8/25/25 5:18:06 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $GE
    $IEX
    $MDT
    $WTS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GE Aerospace

    SC 13G/A - GENERAL ELECTRIC CO (0000040545) (Subject)

    11/12/24 12:54:20 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    Amendment: SEC Form SC 13G/A filed by Watts Water Technologies Inc.

    SC 13G/A - WATTS WATER TECHNOLOGIES INC (0000795403) (Subject)

    11/5/24 3:09:24 PM ET
    $WTS
    Metal Fabrications
    Industrials

    Amendment: SEC Form SC 13G/A filed by IDEX Corporation

    SC 13G/A - IDEX CORP /DE/ (0000832101) (Subject)

    10/7/24 1:03:55 PM ET
    $IEX
    Fluid Controls
    Industrials

    $GE
    $IEX
    $MDT
    $WTS
    Financials

    Live finance-specific insights

    View All

    IDEX Corporation Announces Increase to Share Repurchase Authorization and Declares Regular Quarterly Cash Dividend

    IDEX Corporation (NYSE:IEX) announced today that its Board of Directors has increased the Company's share repurchase authorization, bringing total repurchase capacity to $1 billion from approximately $440 million remaining as of June 30, 2025. "This announcement highlights the confidence we have in our growth strategy and underscores our proven ability to consistently generate strong free cash flow. For the full year 2025, we expect to return at least 70% of free cash flow to shareholders through dividends and share repurchases. We plan to take a dynamic approach to capital allocation as we invest in growth opportunities that position IDEX for continued value creation and success," said E

    9/18/25 4:52:00 PM ET
    $IEX
    Fluid Controls
    Industrials

    GE Aerospace Board of Directors Authorizes Regular Quarterly Dividend

    CINCINNATI, Sept. 18, 2025 /PRNewswire/ -- The Board of Directors of GE Aerospace (NYSE:GE) today declared a $0.36 per share dividend on the outstanding common stock of the Company. The dividend is payable October 27, 2025, to shareholders of record at the close of business on September 29, 2025. The ex-dividend date is September 29, 2025. About GE AerospaceGE Aerospace (NYSE:GE) is a global aerospace propulsion, services, and systems leader with an installed base of approximately 49,000 commercial and 29,000 military aircraft engines. With a global team of approximately 53,00

    9/18/25 1:30:00 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    Medtronic reports first quarter fiscal 2026 financial results

    11th quarter in a row of mid-single digit organic revenue growth;Poised to accelerate growth GALWAY, Ireland, Aug. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2026 (FY26), which ended July 25, 2025. Key Highlights Revenue of $8.6 billion, adjusted revenue of $8.5 billion, increased 8.4% as reported and 4.8% organicGAAP diluted EPS of $0.81 increased 1%; non-GAAP diluted EPS of $1.26 increased 2%Company raises FY26 EPS guidance; reiterates FY26 organic revenue growth guidanceCardiac Ablation Solutions revenue increased nearly 50%, incl

    8/19/25 6:45:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $GE
    $IEX
    $MDT
    $WTS
    Leadership Updates

    Live Leadership Updates

    View All

    GE AEROSPACE AND BETA TECHNOLOGIES PARTNER TO ADVANCE HYBRID ELECTRIC FLIGHT

    Companies to co-develop hybrid electric turbogenerator for defense and civil applications, enabling U.S. Advanced Air MobilityHybrid electric capabilities enable longer range, higher speed, lower operating cost and higher payload compared to other aircraft in the same segmentGE Aerospace to make an equity investment of $300 million in BETA Technologies, Inc.CINCINNATI, Sept. 4, 2025 /PRNewswire/ -- GE Aerospace (NYSE:GE) and BETA Technologies Inc. ("BETA") announced today a new strategic partnership and equity investment agreement, subject to regulatory approval, to accelerate the development of hybrid electric aviation by combining BETA's rapid innovation approach with GE Aerospace's global

    9/4/25 6:20:00 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company

    GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to become fully independent.  Chad brings over 25 years of financial leadership experience across healthcare, consumer, and industrial sectors. Most recently, he served as CFO at BIC (BB:PA), a pu

    7/8/25 8:45:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Medtronic Board appoints Dr. Joon Lee as a new director

    GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board. "We are thrilled to welcome Dr. Lee, a highly respected interventional cardiologist and healthcare executive, to Medtronic's Board of Directors," said Geoff Martha, chairman and chief executive officer. "Dr. Lee brings deep expertise as a clinical researcher, academic leader, and physician executive with dec

    6/23/25 4:15:00 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care